7VOA

Crystal structure of SARS-CoV-2 RBD in complex with aRBD5

Summary for 7VOA

Entry DOI	10.2210/pdb7voa/pdb
Descriptor	alpaca nanobody, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
Functional Keywords	viral protein-antiviral protein complex, viral protein/antiviral protein
Biological source	Vicugna pacos More
Total number of polymer chains	2
Total formula weight	37205.51
Authors	Ma, H.,Zeng, W.H.,Jin, T.C. (deposition date: 2021-10-13, release date: 2022-08-10, Last modification date: 2023-11-29)
Primary citation	Ma, H.,Zhang, X.,Zheng, P.,Dube, P.H.,Zeng, W.,Chen, S.,Cheng, Q.,Yang, Y.,Wu, Y.,Zhou, J.,Hu, X.,Xiang, Y.,Zhang, H.,Chiu, S.,Jin, T. Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell Res., 32:831-842, 2022 Cited by PubMed: 35906408 DOI: 10.1038/s41422-022-00700-3 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.8 Å)

Structure validation